𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new cancer-associated antigen defined by a monoclonal antibody against a synthetic carbohydrate chain

✍ Scribed by Yoshito Yamashita; Yong Suk Chung; Tetsuji Sawada; Yasuyuki Kondo; Koji Hirayama; Akimasa Inui; Bunzo Nakata; Masahiro Okuno; Ryuichi Horie; Takashi Saito; Keiichi Murayama; Reiji Kannagi; Michio Sowa

Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
985 KB
Volume
58
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Carbohydrate antigens can be designed by referring to previously defined carbohydrate structures. We have generated a novel monoclonal antibody (MAb) (Flα‐75) against an artificially designed antigen (Flα), using organic‐synthetic chemistry methods and hybridoma technology. Flα (GalβI → 4GlcNAcβI → 6GalNAαI → Ser/Thr) belongs to core type 6 of O‐linked glycans, which has not been previously reported in human cancers. To produce antibodies against Flα, a glycolipid was synthesized which carries the carbohydrate portion of Flα on a ceramide foundation (GalβI → 4GlcNAcβI → 6GalNAcαI → Cer). The MAbs we obtained (Flα‐75, Flα‐87) specifically recognized Flα and had only a very weak or no cross‐reactivity with other glycolipids similar to Flα. We investigated the expression of Fin in human tissues, including 110 gastric cancers, 73 colon cancers and 42 pancreatic cancers. Flα was found in human cancerous tissues but not in normal adult tissues. The rate of positive staining with Flα‐75 was 80.0% for gastric cancer, 52.4% for pancreatic cancer and 38.4% for colon cancer. Flα‐75 also reacted with the tissues neighboring gastric and pancreatic tumors but not intensely. Among fetal tissues, Flα‐75 reacted with the pyloric glands of the stomach, the centro‐acinar cells of the pancreas, the convoluted tubules of the kidney and the terminal bronchioles of the lung.

📜 SIMILAR VOLUMES

A novel gastric-cancer-associated mucin
A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4
✍ Hirofumi Akashi; Yuji Hinoda; Fumio Itoh; Masaaki Adachi; Takao Endo; Kohzoh Ima 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 517 KB

De-glycosylation of mucins may expose new tumorassociated core protein epitopes. In this study, to attempt to develop useful markers for gastric cancers, we have purified and de-glycosylated gastric mucin and tried to establish monoclonal antibodies (MAbs). A MAb designated A3D4 among established MA

L3P40-50—a new lung-tumor-associated 40-
L3P40-50—a new lung-tumor-associated 40- to 50-kDa antigen defined by a monoclonal antibody (L3)
✍ Fred-Thomas Brezicka; Sante Olling 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 515 KB

A monoclonal antibody (MAb), designated L3, was raised against a human-lung-adenocarcinoma-derived cell line, A549. lmmunohistological studies showed reactivity of MAb L3 with 70 to 90% of lung tumors representing the 4 major histotypes. Strongest reactivity was seen with squamous-cell cancer and a

Haptoglobin-β chain defined by monoclona
Haptoglobin-β chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer
✍ Seiichi Saito; Yasuko Murayama; Yuzhuo Pan; Takenobu Taima; Tsutomu Fujimura; Ki 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 773 KB

## Abstract In our previous study, monoclonal antibody RM2, established toward the glycosyl epitope, reflected grade of malignancy of prostate cancer cells whereas RM2 reactivity to benign glands was negative or weak. RM2 reactivity was also detected in stroma, suggesting the glycoprotein RM2 recog

Carbohydrates as antigenic determinants
Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system
✍ Masafumi Ito; Eiji Suzuki; Masaharu Naiki; Fujiro Sendo; Shigeru Arai 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 947 KB

## Abstract Two monoclonal antibodies (KH‐1 and KH‐2) against a transplanted fibrosarcoma (KMT‐17) in WKA rats were produced by fusing a mouse myeloma (P~3~‐X63‐Ag8.653) with spleen cells from syngeneic rats hyperimmunized with KMT‐17. Both antibodies showed complement‐dependent cytotoxicity agains